With the exception of the study by Song et al. [20], which showed that TERT promoter mutations were not associated with age, the other results of association between TERT promoter mutations and clinicopathological characteristics of FTC were consistent with those of the studies by Wang et al. [26], Muzza et al. [30], and Song et al. [20]. The gene discussed is TERT; the disease is thyroid cancer, nonmedullary, 2.